Page 2 - Rev Dis Primers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Napp announces authorisation of REZZAYO® (rezafungin) in Great Britain by the UK Medicines and Healthcare Products Regulatory Agency for the treatment of invasive candidiasis in adults¹

Napp announces authorisation of REZZAYO® (rezafungin) in Great Britain by the UK Medicines and Healthcare Products Regulatory Agency for the treatment of invasive candidiasis in adults¹
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomGreat britainP lewis whiteBen davidAsia pacificAntimicrob chemotherHealthcare products regulatory agencyCardiff university centre for trials researchTrademark of cidara therapeutics incData review committeeMycology reference laboratoryNapp pharmaceuticalsNapp pharmaceuticals limitedMedical mediaPharmaceuticals limited

SciELO - Brasil - Comparison of genotyping methods and toxin gene profiles of Staphylococcus aureus isolates from clinical specimens Comparison of genotyping methods and toxin gene profiles of Staphylococcus aureus isolates from clinical specimens

SciELO - Brasil - Comparison of genotyping methods and toxin gene profiles of Staphylococcus aureus isolates from clinical specimens Comparison of genotyping methods and toxin gene profiles of Staphylococcus aureus isolates from clinical specimens
scielo.br - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scielo.br Daily Mail and Mail on Sunday newspapers.

United statesEstado de pernambucoEstado do rioFoster cityOswaldo cruzRio grande do sulRio de janeiroMinas geraisJ clin microbiolClin microbiolAggeu magalhUniplex pcrsOswaldo cruz foundation health research ethics committeeFood research institute madisonClin chem labMicrobiol rev

Mundipharma announces European approval of REZZAYO (rezafungin) for the treatment of Invasive Candidiasis in adults

Mundipharma announces European approval of REZZAYO (rezafungin) for the treatment of Invasive Candidiasis in adults
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesAntimicrob chemotherOliver cornelyStefan klotterAsia pacificYuri martinaCommittee for medicinal products human useEuropean unionCommunity registerUniversity hospital cologneEuropean commissionCidara therapeutics incData review committeeFor tradeMedical mediaMedicinal products

Mundipharma announces European approval of REZZAYO® (rezafungin) for the treatment of Invasive Candidiasis in adults

Mundipharma announces European approval of REZZAYO® (rezafungin) for the treatment of Invasive Candidiasis in adults
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesAsia pacificOliver cornelyYuri martinaAntimicrob chemotherCommittee for medicinal products human useData review committeeEuropean unionUniversity hospital cologneEuropean commissionCidara therapeutics incCommunity registerFor tradeMedical mediaMedicinal products

Mundipharma announces European approval of REZZAYO® (rezafungin) for the treatment of Invasive Candidiasis in adults

Mundipharma today announced rezafungin (rezafungin acetate) has been approved in the European Union (EU) for the treatment of invasive candidiasis in adults. The approval by the European Commission (EC) follows the positive opinion of the Committee.

United statesYuri martinaAsia pacificOliver cornelyAntimicrob chemotherProduct serviceUniversity hospital cologneCommunity registerEuropean unionData review committeeEuropean commissionCommittee for medicinal products human useCidara therapeutics incInvasive candidiasisMedicinal productsHuman use